Acta Pharmaceutica Sinica B is an Open Access journal

  • This journal is a peer reviewed, Open Access journal.

    User Rights

    All articles published Open Access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by your choice of one of the following user licenses:

    Creative Commons Attribution (CC-BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.

    Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).

    Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

    No publication fee

    Unlike most open access journals, to publish an article in this journal you do not have to pay a fee as an author, institution or research funder to cover the costs associated with publication. The journal is funded by the Institute of Materia Medica, Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.

    Funding Body Agreements

    Elsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body Open Access policies and may also be reimbursed for their publication fees.

    Author Rights

    For Open Access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.

    Learn More about:
    Publishing Open Access with Elsevier
    Funding body agreements
    Open Access license policy

Advertisement

advert image